HighTower Advisors »

Turn Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Turn Therapeutics (TTRX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Turn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Turn Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Turn Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $78k 20k 3.94

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Turn Therapeutics

Wellington Shields & Co
DDFG
Vanguard Group
XTX Topco
Brown Brothers Harriman & Co.
HighTower Advisors
RVW Wealth
Jane Street
Geode Capital Management
Miracle Mile Advisors
Tamar Securities
LPL Financial
Hodges Capital Management
Ronald Blue Trust
Wells Fargo & Company

View all funds holding Turn Therapeutics